Valeant Pharmaceuticals is now Canada’s largest company by market value, skirting past RBC at 11:21 a.m. today, according to Bloomberg.

“Valeant surged 4.5 percent to C$326.10 per share for a market value of C$111.3 billion ($85.7 billion) at 11:21 a.m. in Toronto. That eclipsed Royal Bank’s C$108.3 billion market value, according to data compiled by Bloomberg.”

Also read:

Consider private equity for untapped healthcare opportunities

Median cost of U.S. nursing home tops $91,000 a year

Don’t take good health for granted

Originally published on

Add a comment

You must be logged in to comment.

Register on